Archive for 2008
Medical Patent Opportunities in Bloodless Solutions
Medical patent opportunities for "bloodless solutions" have been actualized in a wide range of medical devices in technology. With patients increasingly concerned with the risks associated with transfusions, the trend appears to be growing.
Patent Pending Drug for Artherosclerosis
Merck & Co, Inc., in collaboration with Arena Pharmaceuticals, is taking a patent pending drug into Phase One of a clinical trial (PharmaLive, January 25, 2008). Merck’s second generation niacin receptor agonist is a combatant to artherosclerosis. Will the patented drug enter the market? ... Read More
Patent Revocation: A Significant Risk?
I posted the information below in a separate blog I run for people interested in non-medical patents. However, I thought it would be of use to this community as well. The question being discussed is how ‘at-risk’ patent holders are for having their patents revoked. And the short answer is…very little. . T... Read More
A Patent-Pending Patent Protector?
How are you imbuing authenticity within your product's concept? When an idea is innovative enough, being first is itself the strongest voice of authenticity.
Patent Approved for Hythiam’s Alcohol Treatment Program
Interest in the mind-body connection in particular is a trend that has continued to grow over the last several years, and you can see this in patented products in virtually every category, including fitness, publishing, alternative health practices, the expansion of nutraceuticals into even our soda, etc.
